Etelcalcetide (Parsabiv) for Secondary Hyperparathyroidism in Adults With Chronic Kidney Disease on Hemodialysis.
Etelcalcetide (Parsabiv) for Secondary Hyperparathyroidism in Adults With Chronic Kidney Disease on Hemodialysis.
P T. 2018 Jul;43(7):396-399
Authors: Patel J, Bridgeman MB
Abstract
Etelcalcetide (Parsabiv) for hyperparathyroidism in adults with chronic kidney disease on hemodialysis.
PMID: 30013296 [PubMed]
Source: P and T - Category: Drugs & Pharmacology Tags: P T Source Type: research
More News: Chronic Kidney Disease | Dialysis | Drugs & Pharmacology | Hemodialysis | Hyperparathyroidism | Urology & Nephrology